1 / 6
文档名称:

2010全国生物材料大会论文集之 (133).pdf

格式:pdf   页数:6
下载后只包含 1 个 PDF 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

2010全国生物材料大会论文集之 (133).pdf

上传人:一文千金 2011/12/24 文件大小:0 KB

下载得到文件列表

2010全国生物材料大会论文集之 (133).pdf

文档介绍

文档介绍:Gene expression profile of colon cancer cell lines
treated with SN38

Ying Wang Jiajia Chen, Bairong Shen*
School of life Science and Technology Center for Systems Biology
Tongji University,Shanghai, China Soochow University,Suzhou, China
*Corresponding author: bairong.******@suda.
Åsa Wallin, Xiao-feng Sun*
Divisions of Oncology, Department of Clinical and Experimental Medicine
Linköping University,Linköping, Sweden
*Corresponding author: xiao-feng.******@


Abstract—Irinotecan has been proven to have anti-tumor effects Generally, colorectal cancer treatments include surgery,
and is used for chemotherapy in colorectal cancer. It is a prodrug chemotherapy and radiation therapy. Surgery is the main
converted by carboxylesterase to form the active metabolite 7- treatment for CRC. However, when considering the type and
ethyl-10-hydroxy-camptothecin (SN38). To identify the potential stage of the cancer, as well as the patient's individual
molecular function of SN38 in colon cancer, we investigated the differences, many treatments may be ineffective and some even
gene expression profile of colon cancer cell lines treated with have strong side effects on the patients.
SN38 and tried to reveal critical genes and biological pathways
involved in the response of colon cancer cells to SN38 treatment. The development of microarray technology